HIGHLIGHTS
- who: Tatjana Welzel from the University Children`s Hospital Basel (UKBB), University of Basel, Spitalstrasse have published the article: Tapering of biological treatment in autoinflammatory diseases: a scoping review, in the Journal: Rheumatology Research Alliance (CARRA) survey the physicians' attitudes towards tapering in sJIA were assessed; 39% preferred tapering biological treatment over 2-6 months and favoured interval prolongation [37]. Particularly for children, interval prolongation often increases quality of life due to a reduced hospitalization rate for infusions or decreased frequency of s.c injections, which are often associated with discomfort, fear and worries [38]. Furthermore, interval . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.